Molecular Nutrition & Food Research · 2007 · 71 citations · 15 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyCancer PharmacologyStructure-activity RelationshipsIn Vitro PharmacologyMedicinal PlantsMetabolite ExtractionAnticancer ActivityBioactive Fungal MetabolitesPharmacological ScreeningPhytochemicals In Cancer PreventionSpectroscopic FactorSpectroscopic IdentificationSpectroscopic Reduction
Ganoderma lucidum is a well-known mushroom with various pharmacological effects that has been used for health and longevity purposes. The objective of this study was to investigate the anti-invasive effect of lucidenic acids isolated from a new G. lucidum strain (YK-02) against human hepatoma carcinoma (HepG(2)) cells. Triterpenoid components in the ethanol extract of G. lucidum (YK-02) were separated by means of a semi-preparative RP HPLC. Four major peaks were separated and crystallized from triterpenoids fraction, and were identified as lucidenic acids A, B, C, and N according to their spectroscopic values of (1)H NMR and MS. Treatment of the lucidenic acids (50 microM) in the presence of 200 nM phorbol 12-myristate 13-acetate (PMA) after 24 h of incubation all resulted in significant inhibitory effects on PMA-induced MMP-9 activity and invasion of HepG(2 )cells. The results indicate that the lucidenic acids isolated from G. lucidum (YK-02) are anti-invasive bioactive components on hepatoma cells.
15
A new in vitro assay for quantitating tumor cell invasion.
L A Repesh · PubMed · 1989 · 294 citations
Medicine, Cell Biology, Oncology +17
Yuan-yuan Wang, Kay‐Hooi Khoo, Shui‐Tein Chen et al. · Bioorganic & Medicinal Chemistry · 2002 · 274 citations